Bifidobacterium Brevis understanding of the process

Bifidobacterium Brevis was in 1899 by the French scholar Tissier child nutrition from breast milk isolated from the feces of an anaerobic Gram-positive bacteria, often forked end, hence the name of bifidobacteria.
Bifidobacterium breve - understanding of the process: Since the past two decades the rise of micro-ecology and medical progress of the revolution, so that bifidobacteria increasingly recognized the importance of research. Since bifidobacteria products can be widely used in the world, the masses have recognized its importance. Especially in infants and young children to be able to provide a unique intestinal health protection, effectively reducing infant intestinal infection incidence. The main role of bifidobacteria and widely used, but also for the study of bifidobacteria laid the foundation for the development. After many experts and scholars continue to explore experiments have confirmed that bifidobacteria are the most beneficial intestinal flora, reduction in the number of bifidobacteria are disappearing is "unhealthy" state flag, Bifidobacterium is a barometer of human health. Micro-ecological studies in healthy volunteers found that the number of bacteria in the digestive tract has 100 species, their number reached 100 trillion or more. Human gut bacterial populations to increase as people age varies significantly. Baby 3 to 4 days after birth appears intestinal Bifidobacterium Bifidobacterium infants accounted for approximately 25% of total intestinal bacteria; With increasing age, bifidobacteria gradually reduce or even disappear over 65 years the elderly, the number of bifidobacteria decreased to only 7.9%, while gas production pod Clostridium, E. coli and other bacteria in a significant increase in corruption; into old age full of spoilage bacteria of intestinal bifidobacteria almost disappeared. Spoilage bacteria in the gut break down food ingredients, to produce ammonia, amines, ammonia, sulfide, skatole, indole, phenols, and nitrosamines and other toxic substances, human long-term absorption of these toxins, will accelerate the aging-induced cancer, causing arterial sclerosis, liver disorders and other diseases. Increase the number of bifidobacteria in the body in two ways: "nourishing viable in vitro" and "in vivo growth of viable cells." "In vitro nourishing viable" is the oral administration of a certain number of viable bifidobacteria system.


More about:Bifidobacterium Brevis suppliers
From:Lactic acid bacteria